Cohance Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03QK01018
  • NSEID: COHANCE
  • BSEID: 543064
INR
309.45
-2.1 (-0.67%)
BSENSE

Apr 02

BSE+NSE Vol: 3.14 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Granules India
Alivus Life
Sanofi Consumer
Caplin Point Lab
Strides Pharma
Alembic Pharma
Cohance Life
Jubilant Pharmo
Concord Biotech
Rubicon Research
Corona Remedies
Why is Cohance Lifesciences Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 4.15% of over the last 5 years
2
Negative results in Sep 25
  • OPERATING CF(Y) Lowest at Rs 301.03 Cr
  • PBT LESS OI(Q) At Rs 68.17 cr has Fallen at -42.4% (vs previous 4Q average)
  • PAT(Latest six months) At Rs 128.95 cr has Grown at -39.70%
3
With ROE of 9.1, it has a Very Expensive valuation with a 5.5 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -57.97%, its profits have risen by 9.5%
4
100% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
5
Below par performance in long term as well as near term
  • Along with generating -57.97% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cohance Life for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Cohance Life
-71.48%
-1.48
39.13%
Sensex
-4.3%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
21.63%
EBIT Growth (5y)
-1.40%
EBIT to Interest (avg)
50.61
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.71
Tax Ratio
25.59%
Dividend Payout Ratio
0
Pledged Shares
100.00%
Institutional Holding
27.59%
ROCE (avg)
33.20%
ROE (avg)
21.44%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
39
Industry P/E
31
Price to Book Value
3.13
EV to EBIT
32.37
EV to EBITDA
21.32
EV to Capital Employed
3.10
EV to Sales
4.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.36%
ROE (Latest)
10.93%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NO KEY POSITIVE TRIGGERS
-25What is not working for the Company
PAT(Q)

At Rs 40.19 cr has Fallen at -61.2% (vs previous 4Q average

ROCE(HY)

Lowest at 13.59%

OPERATING PROFIT TO INTEREST (Q)

Lowest at 10.47 times

NET SALES(Q)

Lowest at Rs 544.55 cr

PBDIT(Q)

Lowest at Rs 95.35 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 17.51%

PBT LESS OI(Q)

Lowest at Rs 39.30 cr.

EPS(Q)

Lowest at Rs 0.96

Loading Valuation Snapshot...
Here's what is not working for Cohance Life
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 39.30 cr has Fallen at -66.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 118.12 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 40.19 cr has Fallen at -61.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 103.48 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 544.55 cr has Fallen at -16.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 655.38 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Lowest at 10.47 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales - Quarterly
Lowest at Rs 544.55 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 95.35 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 17.51%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 39.30 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.96
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)